IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,971,866 | +915.1% | 1,577,827 | +762.5% | 0.00% | – |
| Q1 2024 | $982,334 | +7.0% | 182,930 | 0.0% | 0.00% | – |
| Q4 2023 | $918,310 | +197.0% | 182,930 | 0.0% | 0.00% | – |
| Q3 2023 | $309,152 | -7.1% | 182,930 | 0.0% | 0.00% | – |
| Q2 2023 | $332,932 | 0.0% | 182,930 | 0.0% | 0.00% | – |
| Q1 2023 | $332,932 | -55.4% | 182,930 | +24.3% | 0.00% | – |
| Q4 2022 | $746,294 | -99.9% | 147,198 | +8.7% | 0.00% | – |
| Q3 2022 | $672,715,000 | +17.4% | 135,355 | -12.1% | 0.00% | – |
| Q2 2022 | $573,018,000 | +1.3% | 154,037 | +52.7% | 0.00% | – |
| Q1 2022 | $565,832,000 | -7.7% | 100,861 | 0.0% | 0.00% | – |
| Q4 2021 | $613,236,000 | +45.9% | 100,861 | +133.8% | 0.00% | – |
| Q3 2021 | $420,174,000 | +13.5% | 43,139 | +66.4% | 0.00% | – |
| Q2 2021 | $370,166,000 | -28.1% | 25,922 | +19.5% | 0.00% | – |
| Q1 2021 | $515,158,000 | – | 21,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
| ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
| Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
| SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
| Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
| Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
| Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
| Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |